← evidence library

Evidence Library

Current

49 sources with this status, each checked with the publisher on the date shown.

• EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure European Association for the Study of the Liver · 2017-05 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 1 claim
• EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis European Association for the Study of the Liver · 2018 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• Nutrition in Chronic Liver Disease EASL Guideline European Association for the Study of the Liver · 2018 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on the management of hepatic encephalopathy European Association for the Study of the Liver · 2022-09 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• Corrigendum to 'EASL clinical practice guidelines on the management of hepatic encephalopathy' [J Hepatol 2022 (77) 807-824] European Association for the Study of the Liver · 2023 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on acute-on-chronic liver failure European Association for the Study of the Liver · 2023 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 2 claims
• EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma European Association for the Study of the Liver · 2025-02 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on liver transplantation European Association for the Study of the Liver · 2024 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on TIPS European Association for the Study of the Liver · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease European Association for the Study of the Liver · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on vascular diseases of the liver European Association for the Study of the Liver · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on the management of autoimmune hepatitis European Association for the Study of the Liver · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL Clinical Practice Guidelines on the management of hepatitis B virus infection European Association for the Study of the Liver · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL-ERN Clinical Practice Guidelines on Wilson's disease European Association for the Study of the Liver and European Reference Network · 2025 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) EASL, EASD and EASO (joint) · 2024 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• Acute Liver Failure Guidelines American College of Gastroenterology · 2023-07 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• AASLD Practice Guidance on acute-on-chronic liver failure and the management of critically ill patients with cirrhosis American Association for the Study of Liver Diseases · 2024-06 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis American Association for the Study of Liver Diseases · 2024 · Tier 2
  Current — checked with the publisher on 2026-09-01 · unread
• Cirrhosis in over 16s: assessment and management (NG50) National Institute for Health and Care Excellence · 2016-07-06 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 23 claims
• Liver disease quality standard (QS152) National Institute for Health and Care Excellence · 2017-06-29 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 1 claim
• Decompensated cirrhosis: an update of the BSG/BASL admission care bundle British Society of Gastroenterology, British Association for the Study of the Liver and Society for Acute Medicine · 2025-04-18 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 1 claim
• Baveno VII - Renewing consensus in portal hypertension Baveno VII Faculty · 2022 · Tier 3
  Current — checked with the publisher on 2026-09-01 · unread
• Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS) International Study Group of Liver Surgery · 2011 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 9 claims
• POL195 - Liver Transplantation: Selection Criteria and Recipient Registration NHS Blood and Transplant · 2026-07-31 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 3 claims
• POL196 - Deceased Donor Liver Distribution and Allocation NHS Blood and Transplant · 2026-08-03 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 5 claims
• Elective Liver Transplant List Mortality: Development of a United Kingdom End-Stage Liver Disease Score Barber K, Madden S, Allen J, et al. · 2011-08-27 · Tier 4
  Current — checked with the publisher on 2026-09-01 · unread
• Advanced therapy medicinal products: regulation and licensing in UK Medicines and Healthcare products Regulatory Agency / GOV.UK · 2015-01-26 · Tier 1
  Current — checked with the publisher on 2026-09-01 · unread
• Cirrhosis NHS · 2025-02-10 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 10 claims
• Alcohol-related liver disease (ARLD) NHS · 2026-07-15 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 11 claims
• Treating paracetamol overdose with intravenous acetylcysteine: new guidance Medicines and Healthcare products Regulatory Agency / GOV.UK Drug Safety Update · 2014-12-11 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 5 claims
• Decompensated Cirrhosis Care Bundle form (Figure 1) British Society of Gastroenterology, British Association for the Study of the Liver and Society for Acute Medicine · 2025-01-12 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 12 claims
• Acute upper gastrointestinal bleeding in over 16s: management (CG141) National Institute for Health and Care Excellence · 2012-06-13 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 5 claims
• Acute upper gastrointestinal bleeding in adults (QS38) National Institute for Health and Care Excellence · 2013-07-30 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 1 claim
• Alcohol-use disorders: diagnosis and management of physical complications (CG100) National Institute for Health and Care Excellence · 2010-06-02 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 5 claims
• Terlipressin: new recommendations to reduce risks of respiratory failure and septic shock in patients with type 1 hepatorenal syndrome Medicines and Healthcare products Regulatory Agency · 2023-03 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 6 claims
• Guidelines on the management of ascites in cirrhosis British Society of Gastroenterology and British Association for the Study of the Liver · 2021 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 3 claims
• British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults British Society of Gastroenterology · 2024-04-16 · Tier 2
  Current — checked with the publisher on 2026-09-01 · 6 claims
• Liver cancer NHS · 2023-06-13 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 8 claims
• Liver cancer NHS inform (NHS Scotland) · 2026-02-16 · Tier 1
  Current — checked with the publisher on 2026-09-01 · 2 claims
• Liver resection: information for patients NHS Tayside · 2024-09 · Tier 5
  Current — checked with the publisher on 2026-09-01 · 3 claims
• Liver resection: information for patients Oxford University Hospitals NHS Foundation Trust · 2024-03 · Tier 5
  Current — checked with the publisher on 2026-09-01 · 1 claim
• Extracorporeal albumin dialysis for acute liver failure (HTG202, formerly IPG316) National Institute for Health and Care Excellence · 2009-09-23 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 4 claims
• Extracorporeal whole liver perfusion for acute liver failure (HTG573, formerly IPG690) National Institute for Health and Care Excellence · 2021-03-31 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 1 claim
• Liver support systems for adults with acute liver failure Cochrane Hepato-Biliary Group · 2026-04-28 · Tier 3
  Current — checked with the publisher on 2026-09-02 · 2 claims
• Service Specification 170003/S: Liver Transplantation Service (Adults) NHS England · 2017-04-10 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 1 claim
• Etranacogene dezaparvovec for treating moderately severe or severe haemophilia B (TA989) National Institute for Health and Care Excellence · 2024-07-24 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 2 claims
• Hemgenix 1 x 10^13 genome copies/mL concentrate for solution for infusion - Summary of Product Characteristics CSL Behring GmbH, via the electronic Medicines Compendium · 2026-04-21 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 4 claims
• The Human Medicines Regulations 2012, regulation 2A: definition of advanced therapy medicinal product UK Statutory Instruments, via legislation.gov.uk · 2012 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 1 claim
• Lumasiran for treating primary hyperoxaluria type 1 (HST25) National Institute for Health and Care Excellence · 2022-11-16 · Tier 1
  Current — checked with the publisher on 2026-09-02 · 1 claim